Physician profile
Matthew Doyle
NPI 1346603826
$91,683.09
in general payments reported to CMS, 2019-2025
18 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,037 · 2020: $2,547 · 2021: $11K · 2022: $6,173 · 2023: $4,677 · 2024: $11K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $8,963 · Food and Beverage: $3,495 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,475.00 |
| Travel and Lodging | $8,963.34 |
| Food and Beverage | $3,494.57 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $66,936.76 | 2021-2025 | |
| Evolution Surgical, INC | $12,895.97 | 2019-2025 | |
| Synthes Gmbh | $8,345.96 | 2023-2025 | |
| Stryker Corporation | $2,093.24 | 2020-2025 | Augment Injectable, Fuseforce, Infinity Adaptis |
| Kerecis Limited | $404.36 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $140.74 | 2019 | |
| Depuy Synthes Sales INC. | $136.48 | 2022 | |
| Smith+Nephew, INC. | $113.95 | 2019-2021 | |
| Paragon 28, INC. | $110.98 | 2019-2024 | Additive Orthopedics |
| Zimmer Biomet Holdings, INC. | $107.10 | 2020 | |
| Organogenesis INC. | $105.61 | 2023 | Puraply |
| Medline Industries LP | $104.67 | 2019 | |
| Eclipse Technology Solutions INC. | $54.21 | 2025 | |
| Integra Lifesciences Corporation | $45.54 | 2020 | |
| Treace Medical Concepts, INC. | $41.82 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $19.11 | 2022 | |
| Saxum Surgical, INC. | $14.30 | 2025 | |
| Bioventus LLC | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.